Literature DB >> 6983988

Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy.

M Iavicoli, U Di Mario, P Pozzilli, J Canalese, L Ventriglia, C Galfo, D Andreani.   

Abstract

An increase in circulating immune complexes (AgAb) of medium size has been observed in diabetics with late complications. This increase may be related either to an increased formation or reduced clearance. Alternatively, both mechanisms may be involved. As medium-sized AgAb determined by the C1q solid phase method are mainly removed from circulation by the fixed phagocytes of the reticulo-endothelial system, we investigated the function of these cells using a colloid clearance test in diabetics with various degrees of microangiopathy. Microaggregated iodinated human serum albumin was injected into 30 diabetic volunteers with severe (group 1), moderate (group 2), and absent (group 3) microangiopathy, and into 40 normal volunteers. The colloid clearance was significantly reduced in diabetics with severe microangiopathy in comparison with patients who had no sign of microangiopathy, or with normal subjects. A significant correlation was found between reduced colloid clearance and increased levels of circulating AgAb determined by C1q solid phase method. Results of this study suggest that the increase in circulating AgAb observed in patients with severe microangiopathy may result from an impaired function of mixed phagocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983988     DOI: 10.2337/diab.31.1.7

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Antibodies to human albumin epitopes in type 1 (insulin-dependent) diabetes mellitus.

Authors:  R Mangili; G C Viberti; D Vergani
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

2.  Evaluation of the presence of circulating immune complexes and their relationship to glomerular IgG deposits in streptozotocin-induced diabetic rats.

Authors:  C K Abrass
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

3.  An investigation into cytotoxic mechanisms in type I diabetes mellitus.

Authors:  E R Richens; J Quilley; M Hartog
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec

4.  Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

Authors:  J L Witztum; U P Steinbrecher; Y A Kesaniemi; M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  The immune response to influenza vaccination in diabetic patients.

Authors:  P Pozzilli; E A Gale; N Visalli; M Baroni; P Crovari; V Frighi; M G Cavallo; D Andreani
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

6.  Some characteristics of neutrophils from diabetic patients and their relation to the levels of circulating immune complexes.

Authors:  R I Barañao; L S Rumi; P A Tesone; V G Foglia
Journal:  Acta Diabetol Lat       Date:  1988 Jan-Mar

7.  Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig.

Authors:  J L Witztum; U P Steinbrecher; M Fisher; A Kesaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Circulating immune complexes in patients with diabetes mellitus.

Authors:  C K Abrass; D Heber; J Lieberman
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

9.  The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.

Authors:  U Di Mario; D Q Borsey; G Contreas; C V Prowse; B F Clarke; D Andreani
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.